Search results
Results from the WOW.Com Content Network
Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] which is used in the treatment of schizophrenia, bipolar mania, [9] bipolar depression, [10] and as an add-on therapy for major depressive disorder. [6]
Vraylar (cariprazine) – atypical antipsychotic used to treat schizophrenia and bipolar mania; W. Wellbutrin IR, SR or XL – an antidepressant of the ...
Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04
Currently approved antipsychotic drugs include Vanda Pharmaceuticals' Fanapt, AbbVie's Vraylar and generic drugs such as olanzapine, quetiapine and aripiprazole, among others.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Vraylar: AbbVie's antipsychotic. Austedo, Austedo XR: Teva's Huntington's disease treatment. Breo Ellipta: GSK's lung condition and asthma treatment. Xifaxan: Salix's irritable bowel syndrome drug ...
The 15 drugs accounted for $41 billion, or 14%, of total Medicare Part D spending between Nov. 1, 2023, and Oct. 1, 2024.
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...